The monitor sn (b)(4) was returned and evaluated at the distributor.The evaluation included review of downloaded software flag files on the day of the event and incoming functional testing.The review of the software flags consisted of an analysis of the downloaded data to identify any fault flags or unusual patterns of software flags.The software flag files did not suggest a device malfunction.During the incoming functional testing, a 1hz simulated normal sinus rhythm signal was applied to the monitor, followed by a 5hz simulated treatable arrhythmia signal which verified proper performance of the detection algorithm.During the transition to the 5hz signal, the device was confirmed to properly enter into a treatment sequence which includes a verification of the audio messaging and siren alarms, as well as a test of the pulse delivery circuitry.The pulse delivery circuitry test verified proper charging of the high voltage capacitors and proper delivery of five full energy 150j biphasic pulses.The functional testing confirmed proper response button functionality, ecg acquisition, detection algorithm performance, and pulse delivery functionality.There is no indication of a product malfunction.Device evaluation of electrode belt sn (b)(4) has been completed.All gels were deployed.During the incoming functional testing, a 1hz simulated normal sinus rhythm signal was applied to the ecg electrodes.The pulse delivery circuitry test verified proper delivery of full energy 150j biphasic pulse.The functional testing confirmed proper ecg acquisition and pulse delivery functionality.There is no indication of a product malfunction.Manufacture dates: monitor: 11/20/2014, electrode belt: 3/28/2019.
|
A us distributor contacted zoll to report that a patient passed away on (b)(6) 2021 while wearing the lifevest.It was reported that medical staff was present with the patient when they passed away.Review of the patient's download data revealed that on the day of passing, the patient received an inappropriate treatment from the lifevest at 06:06:00.The patient's rhythm at the time of the treatment was obscured by cpr and motion artifact, the patient's post-shock rhythm was asystole.The patient remained in asystole until the electrode belt was disconnected at 06:06:23.The response buttons were not pressed during the event.Cpr and motion artifact contributed to the false detection.There is no indication that the lifevest caused or contributed to the patient's passing as the patient was in a non-life-sustaining rhythm prior to treatment delivery.
|